50% off Premium Yearly

NYSE:MCY
This summary was created by AI, based on 10 opinions in the last 12 months.
Mercury General Corp (MCY) has garnered strong attention from analysts as a leading property and auto insurance provider across 11 U.S. states, particularly noted for its robust performance in California. Recent earnings reports highlighted a remarkable growth in earnings per share, exceeding analyst expectations by 60%, alongside a significant 13% increase in premiums earned. The stock is regarded favorably given its appealing valuation metrics, trading at a low price-to-earnings ratio and exhibiting a robust return on equity. Analysts have continuously recommended strategic stop losses, emphasizing a potential upside ranging from 17% to 29% depending on market conditions and target prices set between $80 and $120. Such positive indicators reflect confidence in Mercury General's sustained growth and stability in an evolving insurance market.
Mercury General Corp is a American stock, trading under the symbol MCY (previously MCY-N on Stockchase) on the New York Stock Exchange (MCY). It is usually referred to as NYSE:MCY or MCY
In the last year, 10 stock analysts issued a Buy, Sell, or Hold rating on MCY (previously MCY-N on Stockchase). 10 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Mercury General Corp.
Mercury General Corp was recommended as a Top Pick by Rick Aster on 2004-03-19. Read the latest stock experts ratings for Mercury General Corp.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Mercury General Corp.
Mercury General Corp is followed by 18 investors on Stockchase and is a trending stock that is worth watching.
On 2026-06-16, Mercury General Corp (MCY) stock closed at a price of $102.61.
We reiterate MCY, a property and auto insurance provider with 6300 agents in 11 US states as a TOP PICK. Recently reported earnings per share growth was 60% higher than analyst expectations, with premiums earned up 13% -- double the growth expected. It trades at 9x earnings, 2.2x book and supports a robust ROE of 33%. We continue to recommend a stop at $89, looking to achieve $120 -- upside potential of 17%. Yield 1.3%
(Analysts’ price target is $120.00)